Nuclear factor–κB activation is associated with somatic and germ line RET mutations in medullary thyroid carcinoma
Authors:
- David LlobetDLDavid Llobet
- Maria SantacanaMSMaria Santacana
- Didac MauricioDidac Mauricio
- Mario EncinasMEMario Encinas
- Xavier Matias-GuiuXMXavier Matias-Guiu
- 1 July 2008
- journal article
- Published by Elsevier in Human Pathology
- Vol. 39 (7) , 994-1001
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Molecular mechanisms involved in differentiated thyroid cancer invasion and metastasisCurrent Opinion in Oncology, 2007
- A Novel Activating Mutation in the RET Tyrosine Kinase Domain Mediates Neoplastic TransformationMolecular Endocrinology, 2006
- NF-kB in development and progression of human cancerVirchows Archiv, 2005
- The Glu632-Leu633 deletion in cysteine rich domain of Ret induces constitutive dimerization and alters the processing of the receptor proteinOncogene, 1999
- Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinomaJournal of Endocrinological Investigation, 1998
- Molecular analysis of the RET proto-oncogene in patients with sporadic medullary thyroid carcinoma: a novel point mutation in the extracellular cysteine-rich domainEuropean Journal of Endocrinology, 1997
- Identification of a novel somatic mutation in the RET proto-oncogene in a patient with sporadic medullary thyroid carcinomaHuman Mutation, 1997
- RETProto-Oncogene Mutations in Multiple Endocrine Neoplasia Type 2 and Medullary Thyroid CarcinomaHormone Research, 1997
- Somatic mutations in the RET proto‐oncogene in sporadic medullary thyroid carcinomaClinical Endocrinology, 1996
- Analysis ofRET protooncogene point mutations distinguishes heritable from nonheritable medullary thyroid carcinomasCancer, 1995